Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model

Clinical Science

Volumn 127, Issue 2, 2014, Pages 77-89

  Selvamani, Amutha ^a   Williams, Madison H ^a   Miranda, Rajesh C ^a   Sohrabji, Farida ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Biomarker; MicroRNA; Middle cerebral artery occlusion; Principal component analysis; Sex difference; Small non coding RNA; Stroke

Indexed keywords

BIOLOGICAL MARKER; GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 127 3P; MICRORNA 136; MICRORNA 139 5P; MICRORNA 15A; MICRORNA 15B; MICRORNA 199A 3P; MICRORNA 19B; MICRORNA 222; MICRORNA 32; MICRORNA 335; MICRORNA 338 3P; MICRORNA 33A; MICRORNA 363; MICRORNA 424; MICRORNA 495; MICRORNA 543; MICRORNA 92A; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ADULT; AGE; AGE DIFFERENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC MARKER; MALE; MIDDLE AGED; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; RAT MODEL; SEX DIFFERENCE; SIGNAL TRANSDUCTION; AGING; ANIMAL; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PROCEDURES; TIME;

AGING; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATIDYLINOSITOL 3-KINASES; RATS; SEX FACTORS; STROKE; TIME FACTORS;

EID: 84897543182     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130565     Document Type: Article

References (55)

1. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., Hailpern S. M., Ho M., Howard V., Kissela B. et al. (2008) Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25-e146.
2. Rojas J. I., Zurrú M. C., Romano M., Patrucco L. and Cristiano E. (2007) Acute ischemic stroke and transient ischemic attack in the very old-risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur. J. Neurol. 14, 895-899.
3. Turtzo L. C. and McCullough L. D. (2010) Sex-specific responses to stroke. Future Neurol. 5, 47-59.
4. Cheong J. L. and Cowan F. M. (2009) Neonatal arterial ischaemic stroke: obstetric issues. Semin. Fetal Neonatal Med 14, 267-271.
5. Roquer J., Segura T., Serena J. and Castillo J. (2009) Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc. Dis. 27, 25-37.
6. Niewada M., Kobayashi A., Sandercock P. A., Kamiński B. and Czlonkowska A. (2005) Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology 24, 123-128.
7. Fukuda M., Kanda T., Kamide N., Akutsu T. and Sakai F. (2009) Gender differences in long-term functional outcome after first-ever ischemic stroke. Intern. Med. 48, 967-973.
8. Ambros V. (2001) MicroRNAs: tiny regulators with great potential. Cell 107, 823-826.
9. Jeyaseelan K., Lim K. Y. and Armugam A. (2008) MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39, 959-966.
10. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X. et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006.
11. Rink C. and Khanna S. (2011) MicroRNA in ischemic stroke etiology and pathology. Physiol. Genomics 43, 521-528.
12. Cipollone F., Felicioni L., Sarzani R., Ucchino S., Spigonardo F., Mandolini C., Malatesta S., Bucci M., Mammarella C. et al. (2011) A unique microRNA signature associated with plaque instability in humans. Stroke 42, 2556-2563.
13. Dharap A., Bowen K., Place R., Li L. C. and Vemuganti R. (2009) Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J. Cereb. Blood Flow Metab. 29, 675-687.
14. Tan K. S., Armugam A., Sepramaniam S., Lim K. Y., Setyowati K. D., Wang C. W. and Jeyaseelan K. (2009) Expression profile of microRNAs in young stroke patients. PLoS One 4, e7689.
15. Guo D., Liu J., Wang W., Hao F., Sun X., Wu X., Bu P., Zhang Y., Liu Y., Liu F., Zhang Q. and Jiang F. (2013) Alteration in abundance and compartmentalization of inflammation-related miRNAs in plasma after intracerebral hemorrhage. Stroke 44, 1739-1742.
16. Selvamani A., Sathyan P., Miranda R. C. and Sohrabji F. (2012) An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS One 7, e32662.
17. Selvamani A. and Sohrabji F. (2010) The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1. J. Neurosci. 30, 6852-6861.
18. Selvamani A. and Sohrabji F. (2010) Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiol. Aging 31, 1618-1628.
19. Blondal T., Jensby Nielsen S., Baker A., Andreasen D., Mouritzen P., Wrang Teilum M. and Dahlsveen I. K. (2013) Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59, S1-S6.
20. Vlachos I. S., Kostoulas N., Vergoulis T., Georgakilas G., Reczko M., Maragkakis M., Paraskevopoulou M. D., Prionidis K., Dalamagas T. and Hatzigeorgiou A. G. (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 40, W498-W504.
21. Biernaskie J., Corbett D., Peeling J., Wells J. and Lei H. (2001) A serial MR study of cerebral blood flow changes and lesion development following endothelin-1-induced ischemia in rats. Magn. Reson. Med. 46, 827-830.
22. Longa E. Z., Weinstein P. R., Carlson S. and Cummins R. (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84-91.
23. Nagasawa H. and Kogure K. (1989) Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 20, 1037-1043.
24. Popp A., Jaenisch N., Witte O. W. and Frahm C. (2009) Identification of ischemic regions in a rat model of stroke. PLoS One 4, e4764.
25. Alkayed N. J., Harukuni I., Kimes A. S., London E. D., Traystman R. J. and Hurn P. D. (1998) Gender-linked brain injury in experimental stroke. Stroke 29, 159-166.
26. DiNapoli V. A., Huber J. D., Houser K., Li X. and Rosen C. L. (2008) Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiol. Aging 29, 753-764.
27. Kelly K. A., Li X., Tan Z., VanGilder R. L., Rosen C. L. and Huber J. D. (2009) NOX2 inhibition with apocynin worsens stroke outcome in aged rats. Brain Res. 1292, 165-172.
28. Liu F., Akella P., Benashski S. E., Xu Y. and McCullough L. D. (2009) Sex differences in caspase activation after stroke. Stroke 40, 1842-1848.
29. Martino G., Pluchino S., Bonfanti L. and Schwartz M. (2011) Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol. Rev. 91, 1281-1304.
30. Liao S., Chen W., Kuo J. and Chen C. (2001) Association of serum estrogen level and ischemic neuroprotection in female rats. Neurosci. Lett. 297, 159-162.
31. Simpkins J. W., Rajakumar G., Zhang Y. Q., Simpkins C. E., Greenwald D., Yu C. J., Bodor N. and Day A. L. (1997) Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87, 724-730.
32. Dubal D. B., Kashon M. L., Pettigrew L. C., Ren J. M., Finklestein S. P., Rau S. W. and Wise P. M. (1998) Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 18, 1253-1258.
33. Liu F., Akella P., Benashski S. E., Xu Y. and McCullough L. D. (2010) Expression of Na-K-Cl cotransporter and edema formation are age dependent after ischemic stroke. Exp. Neurol. 224, 356-361.
34. Arumugam T. V., Phillips T. M., Cheng A., Morrell C. H., Mattson M. P. and Wan R. (2010) Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann. Neurol. 67, 41-52.
35. Schroeder E., Vogelgesang S., Popa-Wagner A. and Kessler C. (2003) Neurofilament expression in the rat brain after cerebral infarction: effect of age. Neurobiol. Aging 24, 135-145.
36. Shakarishvili R. and Beridze M. (2008) Proinflammatory reactants as determinants of stroke severity in elderly. Georgian Med. News 162, 23-27.
37. Weber J. A., Baxter D. H., Zhang S., Huang D. Y., Huang K. H., Lee M. J., Galas D. J. and Wang K. (2010) The microRNA spectrum in 12 body fluids. Clin. Chem. 56, 1733-1741.
38. Etheridge A., Lee I., Hood L., Galas D. and Wang K. (2011) Extracellular microRNA: a new source of biomarkers. Mutat. Res. 717, 85-90.
39. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., Benjamin H., Kushnir M., Cholakh H., Melamed N. et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3, e3148.
40. Kosaka N., Iguchi H. and Ochiya T. (2010) Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 101, 2087-2092.
41. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C. W., Röxe T., Müller-Ardogan M. et al. (2010) Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107, 677-684.
42. Li T., Cao H., Zhuang J., Wan J., Guan M., Yu B., Li X. and Zhang W. (2011) Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin. Chim. Acta 14, 66-70.
43. Diehl P., Olivier C., Bode C. and Moser M. (2013) Editorial comment: Reduction of oxidative stress: a new indication for acetylsalicylic acid in coronary artery bypass surgery. Eur. J. Cardiothorac Surg. 43, 1163-1164.
44. Gidlöf O., Smith J. G., Miyazu K., Gilje P., Spencer A., Blomquist S. and Erlinge D. (2013) Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovasc. Disord. 13, 12.
45. Zeng L., Liu J., Wang Y., Wang L., Weng S., Tang Y., Zheng C., Cheng Q., Chen S. and Yang G. Y. (2011) MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front. Biosci. (Elite Ed) 3, 1265-1272.
46. Pigati L., Yaddanapudi S. C., Iyengar R., Kim D. J., Hearn S. A., Danforth D., Hastings M. L. and Duelli D. M. (2010) Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 5, e13515.
47. Yin K. J., Fan Y., Hamblin M., Zhang J., Zhu T., Li S., Hawse J. R., Subramaniam M., Song C. Z., Urrutia R. et al. (2013) KLF11 mediates PPARγ cerebrovascular protection in ischaemic stroke. Brain 136, 1274-1287.
48. Liu X. S., Chopp, M, Wang X. L., Zhang L., Hozeska-Solgot A., Tang T., Kassis H., Zhang R. L., Chen C., Xu J. and Zhang Z. G. (2013) MicroRNA-17-92 cluster mediates the proliferation and survival of neural progenitor cells after stroke. J. Biol. Chem. 288, 12478-12488.
49. Budde H., Schmitt, ,S., Fitzner D., Opitz L., Salinas-Riester G. and Simons M. (2010) Control of oligodendroglial cell number by the miR-17-92 cluster. Development 137, 2127-2132.
50. Zhang L., Zhao H., Zhang X., Chen L., Zhao X., Bai X. and Zhang J. (2013) Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat. Brain Res. Bull. 96, 45-53.
51. Xie R., Cheng M., Li M., Xiong X., Daadi M., Sapolsky R. M. and Zhao H. (2013) Akt isoforms differentially protect against stroke-induced neuronal injury by regulating mTOR activities. J. Cereb. Blood Flow Metab. 33, 1875-1885.
52. Liu F. J., Lim K. Y., Kaur P., Sepramaniam S., Armugam A., Wong P. T. and Jeyaseelan K. (2013) MicroRNAs involved in regulating spontaneous recovery in embolic stroke model. PLoS One 8, e66393.
53. Laufs U., Endres M., Stagliano N., Amin-Hanjani S., Chui D. S., Yang S. X., Simoncini T., Yamada M., Rabkin E., Allen P. G. et al. (2000) Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J. Clin. Invest. 106, 15-24.
54. Weir C. J., Murray G. D., Dyker A. G. and Lees K. R. (1997) Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 314, 1303-1306.
55. Muir K. W., McCormick M., Baird T. and Ali M. (2011) Prevalence, predictors and prognosis of post-stroke hyperglycaemia in acute stroke trials: individual patient data pooled analysis from the Virtual International Stroke Trials Archive (VISTA). Cerebrovasc. Dis. Extra 1, 17-27.